Longitudinal scintigraphic study of parotid and submandibular gland function after total body irradiation in children and adolescents

International Journal of Paediatric Dentistry

Volumn 17, Issue 1, 2007, Pages 34-40

  Bågesund, Mats ^a,b   Richter, Sven ^c   Ringdén, Olle ^c   Dahllöf, Göran ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Centre for Orthodontics and Paediatric Dentistry   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DIAGNOSTIC AGENT; MYELOABLATIVE AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONGITUDINAL STUDY; MALE; PAROTID GLAND; RADIATION EXPOSURE; SALIVATION; SCINTISCANNING; SECRETION; STEM CELL TRANSPLANTATION; SUBMANDIBULAR GLAND; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MYELOABLATIVE AGONISTS; PAROTID GLAND; RADIOPHARMACEUTICALS; SALIVATION; SECRETORY RATE; STEM CELL TRANSPLANTATION; SUBMANDIBULAR GLAND; TECHNETIUM; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 33845381860     PISSN: 09607439     EISSN: 1365263X     Source Type: Journal    
DOI: 10.1111/j.1365-263X.2006.00786.x     Document Type: Article

References (30)

1. Ringdén O, Bolme P, Lönnqvist B, et al. Bone marrow transplantation in children. Clin Transpl 1989; 3: 12-18.
2. Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transpl 1999; 24: 231-245.
3. Dahllöf G, Heimdahl A, Bolme P, Lönnqvist B, Ringdén O. Oral Condition in children treated with bone marrow transplantation. Bone Marrow Transpl 1988; 3: 43-51.
4. Näsman M, Björk O, Söderhäll S, Ringdén O, Dahllöf G. Disturbances in the oral cavity in pediatrie longterm survivors after different forms of antineoplastic therapy. Pediatr Dent 1994; 16: 217-223.
5. Mattsson T, Heimdahl A, Dahllöf G, Nilsson B, Lönnqvist B, Ringdén O. Variables predicting oral mucosal lesions in allogeneic bone marrow recipients. Head Neck 1991; 13: 224-229.
6. Dreizen S. Description and incidence of oral complications. NCI Monogr 1990; 9: 11-15.
7. Fayle SA, Curzon MEJ. Oral complications in pediatrie oncology patients. Pediatr Dent 1991; 13: 289-295.
8. Dahllöf G, Bågesund M, Remberger M., Ringdén O. Risk factors for salivary gland dysfunction in children 1 year after bone marrow transplantation. Oral Oncol 1997; 33: 327-331.
9. Jones LR, Toth BB, Keene HJ. Effects of total body irradiation on salivary gland function and cariesassociated oral microflora in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol 1992; 73: 670-676.
10. Dahllöf G, Bågesund M, Ringdén O. Impact of conditioning regimens on salivary function, caries associated microorganisms and dental caries in children treated with bone marrow transplantation. A four-year longitudinal study. Bone Marrow Transpl 1997; 20: 479-483.
11. Valdés Olmos RA, Kens RB, Takes RP, et al. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands. Cancer 1994; 73: 2886-2893.
12. Hermann GA, Vivino FB, Shnier D, Krumm RP, Mayrin V. Diagnostic accuracy of salivary scintigraphic indices in xerostomic populations. Clin Nucl Med 1999; 24: 167-172.
13. Håkansson U, Jacobsson L, Lilja B, Manthorpe R, Henriksson V. Salivary scintigraphy in subjects with and without symptoms of dry mouth and/or eyes, and in patients with primary Sjögren's syndrome. Scand J Rheumatol 1994; 23: 326-333.
14. Umehara I, Yamada I, Murata Y, Takahashi Y, Okada N, Shibuya H. Quantitative evaluation of salivary gland scintigraphy in Sjögren's syndrome. J Nucl Med 1999; 40: 64-69.
15. Chisin R, Markitziu A, Hoffer S, Shani J, Atlan H. The clinical value of quantitative dynamic scintigraphy in salivary gland disorders. Int J Rad Appl Instrum B 1988; 15: 313-317.
16. Klutmann S, Bohuslavizki KH, Kröger S, et al. Quantitative salivary gland scintigraphy. J Nuclear Med Technol 1999; 27: 20-26.
17. Bågesund M, Richter S, Agren B, Ringdén O, Dahllöf G. Scintigraphic study of the major salivary glands in pediatrie bone marrow transplant recipients. Bone Marrow Transpl 2000; 26: 775-779.
18. Bågesund M, Richter S, Ågren B, Dahllöf G. Correlation between quantitative salivary gland scintigraphy and salivary secretion rates in children and young adults treated for hematological, malignant and metabolic diseases. Dentomaxillofac Radial 2000; 29: 264-271.
19. Sreebny LM. Xerostomia: diagnosis, management and clinical complications. In: Edgar WM, O'Mullane DM (eds). Saliva and Oral Health, 2nd cdn. London: British Dental Association, 1996: 43-66.
20. McDonald S, Meyerowitz C, Smudzin T, Rubin P. Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. Int J Radiat Oncol Biol Phys 1994; 29: 747-754.
21. Zimmerman RP, Mark RJ, Tran LM, Juillard GF. Concomitant pilocarpine during head and neck irradiation is associated with decreased post-treatment xerostomia. Int J Radiat Oncol Biol Phys 1997; 37: 571-575.
22. Rode M, Smid L, Budihna M, Soba E, Rode M, Gaspersic D. The effect of pilocarpine and biperiden on salivary secretion during and after radiotherapy in head and neck cancer patients. Int J Radiat Oncol Biol Phys 1999; 45: 373-378.
23. van. der Reijden WA, van der Kwaak H, Vissink A, Veerman ECI, Amerongen AVN. Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome. Arth Rheum 1996; 39: 57-63.
24. Blom M, Dawidson I, Fernberg JO, Johnson G, Angmar-Månsson B. Acupuncture treatment of patients with radiation induced xerostomia. Eur J Cancer B Oral Oncol 1996; 32: 182-190.
25. Crossner CG. Salivary flow rate in children and adolescents. Swed Dent J 1984; 8: 271-276.
26. Burlage FR, Coppes RP, Meertens H, Stokman MA, Vissink A. Parotid and submandibular/sublingual salivary flow during high dose radiotherapy. Radiother Oncol 2001; 61: 271-274.
27. Valdez IH, Atkinson JC, Ship JA, Fox PC. Major salivary gland function in patients with radiation induced xerostomia: flow rates and sialochemistry. Int J Radiat Oncol Biol Phys 1993; 25: 41-47.
28. Liem IH, Valdes-Olmos RA, Balm AJM., et al. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumors. Eur J Nucl Med 1996; 23: 1485-1490.
29. Cooper JS, Fu K, Marks J, Silverman S. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 1995; 31: 1141-1161.
30. Franzén L, Funegård U, Ericson T, Henriksson R. Parotid gland function during and following radiotherapy of malignancies in the head and neck. Eur J Cancer 1992; 28: 457-462.